Most of Canada to receive emergency alert test today
The federal government will test its capacity to issue emergency alerts today, with the exception of Ontario, where the test will take place on May 15.
Forget taking two to three COVID shots a year. Moderna hopes to roll out a single-dose annual booster to cover the coronavirus, the flu and another common respiratory virus within the next five years.
As COVID-19 continues to mutate, Moderna will need to keep updating the vaccines that turned it into a global household name while trying to make it more convenient for consumers, CEO Stéphane Bancel said in an interview with CNN Business Wednesday.
He estimated a timeline of "three to five years" for the new combined product, and likened the development of the life-saving jab to that of a smartphone.
"You don't get the amazing camera, amazing everything the first time you get an iPhone, but you get a lot of things," he said.
"A lot of us buy a new iPhone every September, and you get new apps and you get refreshed apps. And that's exactly the same idea, which is you'll get COVID and flu and RSV [respiratory syncytial virus] in your single dose."
Having recorded breakneck growth during the pandemic, Moderna is now under pressure to identify its next big frontier.
Bancel believes the COVID-19 pandemic that helped the company rack up tens of billions of dollars in revenue and generate business in more than 70 markets globally could end as soon as this year.
That doesn't mean the virus is going anywhere, he noted.
"I think we are slowly moving — if not already in some countries — to a world where all the tools are available, and everybody can make their own decision based on their risk tolerance," he explained, adding that he believed more people would choose to "live with the virus," much like they do with the flu.
The approach, however, will continue to vary greatly, such as among people who are immunocompromised or in countries like Japan, where it was common to wear masks even before the pandemic, he acknowledged.
And "there's always a 20% probability that we get a very nasty variant that drives very severe disease that has a lot of mutation," he added.
Still, Moderna is determined not to become a one-hit wonder.
The company has more than 40 products in development, and is planning for life well beyond COVID-19, said Bancel.
In addition to an updated annual booster, it is continuing to develop a personalized cancer vaccine, for which new clinical data will drop later this year. Bancel said the product could go up for approval in roughly two years if all goes well.
The company is also exploring a potential monkeypox jab, which is "still in the lab today," Bancel said. The World Health Organization declared the global outbreak of the illness a public health emergency of international concern last month.
And Moderna is looking to catch up to competitors overseas.
Earlier this year, it announced a push into 10 Asian and European markets, including Singapore, Hong Kong, Denmark and the Netherlands. The investments will cost "dozens of millions of dollars" and include hundreds of new hires, said Bancel.
He sees that as just one wave of expansion that will eventually take Moderna from directly operating in 12 countries this year to "40 to 60 countries" over the next three years.
The company also recently signed manufacturing agreements in the United Kingdom, South Korea and Australia, and is hoping to set up one or two more plants in Southeast Asia or North Asia.
Bancel said the new facilities would be crucial to helping adapt its products to different strains of illnesses that develop around the world.
As the world first dealt with the onset of COVID-19, Moderna was one of the handful of large manufacturers that rushed to get their vaccines ready, reducing timelines from years to months. Its stock rallied 434% in 2020 and 143% last year.
But now, like peers Pfizer and BioNTech, the firm's stock has slumped, dropping more than 30% so far this year and 64% from its all-time high a year ago.
Last week, the company revealed that it took a writedown of nearly $500 million in the second quarter, partly because of a sudden cancellation of orders from Covax, the international vaccination program for lower-income countries.
The reversal led to huge losses for the company, which had bought new machines to fulfill those orders, and more importantly, resulted in Covid vaccines being thrown in the trash, said Bancel.
"We ended up destroying the vaccines," he said. "It was really heartbreaking."
The CEO said he wasn't worried about that kind of slide in demand being repeated in richer countries, in part because governments had already shown commitments to use vaccines later this year to avoid reintroducing economic lockdowns.
But "on the low-income country side, yes, I am worried," he said.
The federal government will test its capacity to issue emergency alerts today, with the exception of Ontario, where the test will take place on May 15.
Prince Harry, the Duke of Sussex, has made headlines with his recent arrival in the U.K., this time to celebrate all things Invictus. But upon the prince landing in the U.K., we have already had confirmation that King Charles III won't have time to see his youngest son during his brief visit.
An Ontario man found out that a line of credit he thought was insured actually isn't after his wife of 50 years died.
After more than a century, Boy Scouts of America is rebranding as Scouting America, another major shakeup for an organization that once proudly resisted change.
A first-of-its-kind Canadian research study is working towards a major medical breakthrough for a brain disorder, believed to be caused by repeated head injuries, that can only be detected after death.
In March, Indonesian officials and local fishermen rescued 75 people from the overturned hull of a boat off the coast of Indonesia. Until now, little was known about why the boat capsized.
With Donald Trump sitting just feet away, Stormy Daniels testified Tuesday at the former president's hush money trial about a sexual encounter the porn actor says they had in 2006 that resulted in her being paid to keep silent during the presidential race 10 years later.
An Ontario woman said it would have been impossible to buy a house without her mother – an anecdote that animates the fact that over 17 per cent of Canadian homeowners born in the ‘90s own their property with their parents, according to a new report.
Canadian immigrants threatened by hostile regimes are urging parliamentarians to quickly pass the 'Countering Foreign Interference Act' so they can feel safe living in their adopted home.
An Ontario man says he paid more than $7,700 for a luxury villa he found on a popular travel website -- but the listing was fake.
Whether passionate about Poirot or hungry for Holmes, Winnipeg mystery obsessives have had a local haunt for over 30 years in which to search out their latest page-turners.
Eighty-two-year-old Susan Neufeldt and 90-year-old Ulrich Richter are no spring chickens, but their love blossomed over the weekend with their wedding at Pine View Manor just outside of Rosthern.
Alberta Ballet's double-bill production of 'Der Wolf' and 'The Rite of Spring' marks not only its final show of the season, but the last production for twin sisters Alexandra and Jennifer Gibson.
A mother goose and her goslings caused a bit of a traffic jam on a busy stretch of the Trans-Canada Highway near Vancouver Saturday.
A British Columbia mayor has been censured by city council – stripping him of his travel and lobbying budgets and removing him from city committees – for allegedly distributing a book that questions the history of Indigenous residential schools in Canada.
Three men in Quebec from the same family have fathered more than 600 children.
A group of SaskPower workers recently received special recognition at the legislature – for their efforts in repairing one of Saskatchewan's largest power plants after it was knocked offline for months following a serious flood last summer.
A police officer on Montreal's South Shore anonymously donated a kidney that wound up drastically changing the life of a schoolteacher living on dialysis.